Abstracts
Showing 807 abstracts.
A prospective evaluation of pharmacologic, virologic, and immunologic parameters of lopinavir/ritonavir for HIV-1 infected infants <6 months of age.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Study
P1030
Authors
Ellen Gould Chadwick, John H. Rodman, Paul Palumbo, Deborah Persaud, Jie (Ellen) Chen, Jennifer L. Gardella, Katherine Luzuriaga, Patricia J. Emmanuel, Mobeen H. Rathore, Ram YogevHLA B44 allele and B44 supertype effect on the response to HAART in HIV-1-infected children.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Authors
Akihiko Saitoh, Christine Powell, Terence Fenton, Courtney V. Fletcher, Stephen A. SpectorAnti-HIV antibodies elicited by prime boost vaccination, vCP1452 + AIDSVAX B/B, in newborns of HIV-infected mothers.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Authors
Georgia D. Tomaras, Elizabeth (Betsy) J. McFarland, Daniel Johnson, Petronella Muresan, Terence Fenton, Vicki C. Ashley, David C. Montefiori, John S. Lambert, James McNamara, Elizabeth Hawkins, Barbara E. Heckman, Jennifer S. Read, Scharla Estep, Sanjay Gurunathan, Marc GurwithCX3CR1-249 polymorphism is important determinant of risk of perinatal transmission of HIV-1 in African children.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Authors
Kumud K. Singh, Michael Hughes, Jie (Ellen) Chen, Kelesitse Phiri, C. Rousseau, Louise Kuhn, Beverly A. Jackson, R. Semba, Stephen A. SpectorPharmacokinetics (PK) of atazanivir/ritonavir (ATV/RTV) in HIV-infected infants, children, and adolescents: Pediatric AIDS Clinical Trials Group (PACTG) 1020A.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Study
P1020A
Authors
Jennifer J. Kiser, Richard M. Rutstein, Grace M. Aldrovandi, Pearl Samson, Bobbie L. Graham, Steven M. Schnittman, Elizabeth (Betsy) Smith, Lynne M. Mofenson, Courtney V. FletcherSafety and cell-mediated immune responses to a prime-boost immunization with ALVAC HIV vaccine and AIDSVAX B/B in newborns of HIV-infected mothers (PACTG 326).
Conference
12th Conference on Retroviruses and Opportunistic Infections
Authors
Elizabeth (Betsy) J. McFarland, Daniel Johnson, Petronella Muresan, Terence Fenton, James McNamara, Elizabeth Hawkins, Barbara E. Heckman, Jennifer S. Read, Scharla Estep, Sanjay Gurunathan, Marc Gurwith, John S. LambertCharacterization of medication adherence in children and adolescents with HIV infection
Conference
12th Conference on Retroviruses and Opportunistic Infections
Authors
Paige L. Williams, Betsy Kammerer, Grace Montepiedra, Sharon L. Nichols, Patricia Sirois, Deborah S. Storm, John J. Farley, Kathleen MaleeThe impact of adherence in adolescents initiating HAART: data from the PACTG 381 cohort.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Authors
Bret J. Rudy, Jane C. Lindsey, Michael Hughes, Patricia M. FlynnImmune reconstitution and predictors of virologic suppression and breakthrough in adolescents on HAART: Week 60 results from the PACTG 381 cohort.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Authors
Bret J. Rudy, Jane C. Lindsey, Patricia M. Flynn, Ronald J. Bosch, Craig M. Wilson, Janice Hodge, Michael Hughes, Steven D. DouglasEffect of atazanavir (ATV) on serum cholesterol (CH) and triglyceride (TG) levels in HIV-infected infants, children, and adolescents: Pediatric AIDS Clinical Trials Group (PACTG) 1020A.
Conference
12th Conference on Retroviruses and Opportunistic Infections
Study
P1020A